-
Journal of the American Academy of... Mar 2024Seborrheic dermatitis (SD) is a common skin disease with signs and symptoms that may vary by skin color, associated medical conditions, environmental factors, and... (Review)
Review
Seborrheic dermatitis (SD) is a common skin disease with signs and symptoms that may vary by skin color, associated medical conditions, environmental factors, and vehicle preference. Diagnosis of SD is based on presence of flaky, "greasy" patches, and/or thin plaques accompanied by erythema of the scalp, face, ears, chest, and groin and is associated with pruritus in many patients. The presentation may vary in different skin types and hyper- or hypopigmentation may occur, with or without erythema and minimal or no scaling. While the pathogenesis is not certain, 3 key factors generally agreed upon include lipid secretion by sebaceous glands, Malassezia spp. colonization, and some form of immunologic dysregulation that predisposes the patient to SD. Treatment involves reducing proliferation of, and inflammatory response to, Malassezia spp. Topical therapies, including antifungal agents and low potency corticosteroids, are the mainstay of treatment but may be limited by efficacy and side effects. Few novel treatments for SD are currently being studied; however, clinical trials assessing the use of topical phosphodiesterase-4 inhibitors have been completed. Improving outcomes in SD requires recognizing patient-specific manifestations/locations of the disease, including increased awareness of how it affects people of all skin types.
Topics: Humans; Dermatitis, Seborrheic; Antifungal Agents; Adrenal Cortex Hormones; Erythema; Malassezia
PubMed: 36538948
DOI: 10.1016/j.jaad.2022.12.017 -
Annual Review of Nutrition Aug 2023Riboflavin, in its cofactor forms flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), plays fundamental roles in energy metabolism, cellular antioxidant... (Review)
Review
Riboflavin, in its cofactor forms flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), plays fundamental roles in energy metabolism, cellular antioxidant potential, and metabolic interactions with other micronutrients, including iron, vitamin B, and folate. Severe riboflavin deficiency, largely confined to low-income countries, clinically manifests as cheilosis, angular stomatitis, glossitis, seborrheic dermatitis, and severe anemia with erythroid hypoplasia. Subclinical deficiency may be much more widespread, including in high-income countries, but typically goes undetected because riboflavin biomarkers are rarely measured in human studies. There are adverse health consequences of low and deficient riboflavin status throughout the life cycle, including anemia and hypertension, that could contribute substantially to the global burden of disease. This review considers the available evidence on causes, detection, and consequences of riboflavin deficiency, ranging from clinical deficiency signs to manifestations associated with less severe deficiency, and the related research, public health, and policy priorities.
Topics: Humans; Riboflavin Deficiency; Riboflavin; Causality; Antioxidants; Bone Marrow Failure Disorders; Disease Progression; Lip Diseases
PubMed: 37603429
DOI: 10.1146/annurev-nutr-061121-084407 -
Journal of Inflammation Research 2024As the body's largest organ, the skin harbors a highly diverse microbiota, playing a crucial role in resisting foreign pathogens, nurturing the immune system, and... (Review)
Review
As the body's largest organ, the skin harbors a highly diverse microbiota, playing a crucial role in resisting foreign pathogens, nurturing the immune system, and metabolizing natural products. The dysregulation of human skin microbiota is implicated in immune dysregulation and inflammatory responses. This review delineates the microbial alterations and immune dysregulation features in common Inflammatory Skin Diseases (ISDs) such as psoriasis, rosacea, atopic dermatitis(AD), seborrheic dermatitis(SD), diaper dermatitis(DD), and (MF).The skin microbiota, a complex and evolving community, undergoes changes in composition and function that can compromise the skin microbial barrier. These alterations induce water loss and abnormal lipid metabolism, contributing to the onset of ISDs. Additionally, microorganisms release toxins, like secreted α toxins and proteases, which may dissolve the stratum corneum, impairing skin barrier function and allowing entry into the bloodstream. Microbes entering the bloodstream activate molecular signals, leading to immune disorders and subsequent skin inflammatory responses. For instance, stimulates dendritic cells(DCs) to release IL-12 and IL-23, differentiating into a Th17 cell population and producing proinflammatory mediators such as IL-17, IL-22, TNF-α, and IFN-α.This review offers new insights into the role of the human skin microbiota in ISDs, paving the way for future skin microbiome-specific targeted therapies.
PubMed: 38375021
DOI: 10.2147/JIR.S441100 -
Cureus Nov 2023Introduction Seborrheic dermatitis (SD) is a chronic, inflammatory papulosquamous skin disease. The symptoms and signs of SD are typically managed by topical...
Introduction Seborrheic dermatitis (SD) is a chronic, inflammatory papulosquamous skin disease. The symptoms and signs of SD are typically managed by topical ketoconazole and topical corticosteroids. However, they don't provide a cure for SD, which explains the disease's chronic nature. With this study, we aimed to identify specific dietary modifications that can be implemented as an adjunctive to traditional treatment of SD. Methods A case-control retrospective study. Data was obtained from medical records of patients diagnosed with SD. Patients were invited to participate in an online self-reported questionnaire, and dietary intake was assessed using a validated food frequency questionnaire. The controls were collected by distributing the same questionnaire to healthy adult residents living in Jeddah via social media. Results Two hundred sixty-seven participants were included in the study, 59 of whom were SD patients. Participants who reported consuming the following food types once daily had a higher percentage of SD compared to those without SD: a slice of white bread (p0.002), a cup of rice or pasta (p<0.001), non-acidic fruits (p0.014), leafy green vegetables (p=0.007), other types of vegetables (p=0.001), roasted or fried nuts (p=0.047), raw nuts (p=0.022) and a cup of coffee (p=0.041). When asked about their impression of what food types triggered or relieved their disease, 29 (49.2%) of the diseased participants reported no flare-ups with any kind of food. On the other hand, the following food types were commonly reported to be associated with SD exacerbation: spicy food (16.9%), sweets (16.9%), fried food (13.5%), dairy products (11.9%), and citrus fruits (10.2%). In contrast, citrus fruits, leafy green vegetables (8.5% for each), and the other types of vegetables (6.8%) were frequently observed with SD improvement. Conclusion Several dietary factors have been associated with SD in our cohort. Thus, our findings could offer new insights into the application of adjuvant dietary measures that might play a role in the improvement of SD symptoms and potentially enhance therapeutic outcomes.
PubMed: 38098901
DOI: 10.7759/cureus.48782